Guest Editors
Prof. Cesar Lopez-Camarillo
Email: cesar.lopez@uacm.edu.mx
Affiliation: Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, CDMX 03100, Mexico
Homepage:
Research Interests: microRNAs, lncRNAs, and proteins deregulated in cancer using diverse omics approaches (genomics, proteomics, expression profiling, etc).

Ph.D. Eloísa Ibarra Sierra
Email: ibsiel2606@yahoo.com
Affiliation: Departamento de Investigación, Instituto Estatal de Cancerología “Dr. Arturo Beltrán Ortega”, Acapulco, Guerrero, México
Homepage:
Research Interests: Regulation of gene expression by microRNAs and lncRNAs in cancer

Summary
Cancer continues to be a major global health challenge, and effective treatments remain elusive due to the complex and heterogeneous nature of tumors. Understanding the molecular underpinnings of tumorigenesis is critical for identifying novel therapeutic targets, which may lead to more personalized and effective treatment strategies. This special issue will focus on the latest advances in unraveling the molecular mechanisms driving tumor initiation, progression, and metastasis, as well as the discovery of novel therapeutic targets that hold promise for improving cancer therapy.
We welcome contributions that explore, but are not limited to, the following topics:
Identification of key signaling pathways and molecular drivers of tumorigenesis.
Novel approaches to targeting oncogenes, tumor suppressors, and epigenetic regulators.
Mechanisms of drug resistance and strategies to overcome it.
The role of tumor microenvironment, immune evasion, and inflammation in cancer development.
Innovative therapeutic strategies, including small molecules, biologics, and immunotherapies.
The application of multi-omics approaches (genomics, transcriptomics, proteomics, etc.) to identify therapeutic targets.
Insights from preclinical and clinical studies on novel therapies and biomarkers.
This issue aims to bring together researchers working on the frontier of cancer biology and therapeutics to share their discoveries and insights into how we can effectively combat this devastating disease. By highlighting novel therapeutic targets and mechanisms of action, this special issue seeks to contribute to the development of next-generation cancer treatments.
We encourage original research articles, reviews, and short communications that provide new insights into the molecular mechanisms of cancer and innovative therapeutic approaches.
Keywords
Tumorigenesis, Therapeutic Targets, Molecular Mechanisms, Cancer Signaling Pathways, Drug Resistance
Published Papers